FLUTICASONE FUROATE/ VILANTEROL DRY POWDER INHALER

GlaxoSmithKline UK

Revision date : 2021-09-15

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08 GHS09
Health risk rating 5
Safety risk rating 1
Environmental risk rating 4

Note: Ingredients listed on restricted chemical lists

EC/CAS

209-150-3/557-04-0

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

0.1 - 0.4

EC/CAS

200-559-2

Name of the chemical

Lactose C12H22O11

Concentration

98-<100

General Information

Revision date

2021-09-15

Product name

FLUTICASONE FUROATE/ VILANTEROL DRY POWDER INHALER

Product Synonyms

RELVAR ELLIPTA * BREO ELLIPTA * REVINTY ELLIPTA * REVINTY ELLIPTA 184/22 MCG

Icons in SDS

GHS08 GHS09

Company Information

company name

GlaxoSmithKline UK

e-mail address of the competent person responsible for the Safety Data Sheet

msds@gsk.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H360, H411

Hazard statements

Code

Statements

H360

May damage fertility or the unborn child

H411

Toxic to aquatic life with long lasting effects

Section 2

EU Classification

Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.

Health hazards

Reproductive toxicity Category 1B H360 - May damage fertility or the unborn child.

Environmental hazards

Hazardous to the aquatic environment, Category 2 H411 - Toxic to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Caution - Pharmaceutical agent. May cause reproductive effects. Dangerous for the environment if discharged into watercourses. See section 11 of the SDS for additional information on health hazards.

2.2 Label elements

Label according to Regulation (EC) No. 1272/2008 as amended

Contains

FLUTICASONE FUROATE, LACTOSE, MONOHYDRATE, MAGNESIUM STEARATE, VILANTEROL TRIPHENYLACETIC ACID SALT

Signal word

Danger

Hazard statements

H360 May damage fertility or the unborn child. H411 Toxic to aquatic life with long lasting effects.

Prevention

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection.

Response

P308 + P313 IF exposed or concerned: Get medical advice/attention. P391 Collect spillage.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental label elements

1 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 100 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 100 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.

2.3 Other hazards

Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.